Covaris

NEW YORK (GenomeWeb News) – Genetic Technologies this week announced a settlement and licensing agreement with Promega. Under the terms of the deal, GTG granted Promega "broad rights" to GTG's Intron Sequence Analysis and Genomic Mapping patents. Financial and other terms were not disclosed.

Sygnis said this week that Qiagen has launched the first two products of a series of kits based on Sygnis' proprietary SensiPhi amplification technology.

Eurofins MWG Operon has launched its NGS online shop. Included in the process is the NGS Favourites — predefined service packages that are optimized for specific applications, including genome, transcriptome, and exome sequencing.

NEW YORK (GenomeWeb News) – LGC Genomics and Covaris announced late on Wednesday a partnership to develop solutions for the high-throughput extraction of nucleic acids from formalin-fixed, paraffin-embedded tissue samples.

Covaris last week introduced a single-tube FFPE DNA extraction kit for high-yield, large molecular weight DNA extraction from formalin-fixed, paraffin-embedded tissue samples.

Life Technologies will now offer Covaris' M220 Focused-Ultrasonicator System for use with its Ion Torrent sequencing systems. The system uses isothermal DNA shearing method for preparing DNA for sequencing libraries.

NEW YORK (GenomeWeb News) – Life Technologies will supply Covaris's DNA fragmenting system with its Ion PGM and Ion Proton sequencers, Woburn, Mass.-based Covaris said after the close of the market Wednesday.

Under the deal, BGI will use Covaris' LE220 instrument and consumables as part of its library construction process for next-generation sequencing at several of its laboratories.

According to Matthew Kuruc, COO of PIN member ProFact Proteomics, the network aims to help smaller firms offer complete solutions similar to those increasingly provided by large instrument vendors and to popularize non-mass spec-based proteomics workflows.

Although it's too early to announce biopharma partners, the 13 companies involved in the network are hoping that their collective skills and specialties will attract companies interested in developing drugs targeted to specific proteomic markers in patients.

Pages

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.